Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 690 | 111 | 73 | 71 | 79 |
| Gross Profit | 60 | 120 | 70 | 70 | 70 |
| Operating Expenses | 1,530 | 2,550 | 1,730 | 2,790 | 5,550 |
| Operating Income | -840 | -2,439 | -1,657 | -2,719 | -5,471 |
| Interest Expense | 7 | 26 | 10 | 4 | 10 |
| Other Income | -623 | 25 | 7 | -17 | 1,311 |
| Pre-tax Income | -1,470 | -2,440 | -1,660 | -2,740 | -4,170 |
| Net Income Continuous | -1,476 | -2,437 | -1,664 | -2,740 | -4,171 |
| Net Income | $-1,476 | $-2,437 | $-1,664 | $-2,740 | $-4,171 |
| EPS Basic Total Ops | -28.81 | -45.62 | -33.61 | -55.22 | -84.03 |
| EPS Basic Continuous Ops | -28.49 | -46.60 | -33.28 | -54.91 | -83.76 |
| EPS Diluted Total Ops | -28.81 | -45.62 | -33.61 | -55.22 | -84.03 |
| EPS Diluted Continuous Ops | -28.49 | -46.60 | -33.28 | -54.91 | -83.76 |
| EBITDA(a) | $-780 | $-2,269 | $-1,697 | $-2,669 | $-5,411 |